vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and IMPINJ INC (PI). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $74.3M, roughly 1.0× IMPINJ INC). IMPINJ INC runs the higher net margin — 11.2% vs -9.6%, a 20.8% gap on every dollar of revenue. On growth, IMPINJ INC posted the faster year-over-year revenue change (-0.0% vs -16.8%). Over the past eight quarters, Bioceres Crop Solutions Corp.'s revenue compounded faster (-8.4% CAGR vs -14.9%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Impinj, Inc. is an American manufacturer of radio-frequency identification (RFID) devices and software. The company was founded in 2000 and is headquartered in Seattle, Washington. The company was started based on the research done at the California Institute of Technology by Carver Mead and Chris Diorio. Impinj currently produces EPC Class 1, Gen 2 passive UHF RFID chips, RFID readers, RFID reader chips, and RFID antennas, and software applications for encoding chips, and gathering business ...

BIOX vs PI — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.0× larger
BIOX
$77.6M
$74.3M
PI
Growing faster (revenue YoY)
PI
PI
+16.8% gap
PI
-0.0%
-16.8%
BIOX
Higher net margin
PI
PI
20.8% more per $
PI
11.2%
-9.6%
BIOX
Faster 2-yr revenue CAGR
BIOX
BIOX
Annualised
BIOX
-8.4%
-14.9%
PI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BIOX
BIOX
PI
PI
Revenue
$77.6M
$74.3M
Net Profit
$-7.4M
$8.3M
Gross Margin
46.8%
49.1%
Operating Margin
9.3%
30.5%
Net Margin
-9.6%
11.2%
Revenue YoY
-16.8%
-0.0%
Net Profit YoY
-20.2%
EPS (diluted)
$-0.12
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
PI
PI
Q1 26
$74.3M
Q4 25
$92.8M
Q3 25
$77.6M
$96.1M
Q2 25
$97.9M
Q1 25
$60.6M
$74.3M
Q4 24
$98.8M
$91.6M
Q3 24
$93.3M
$95.2M
Q2 24
$102.5M
Net Profit
BIOX
BIOX
PI
PI
Q1 26
$8.3M
Q4 25
$-1.1M
Q3 25
$-7.4M
$-12.8M
Q2 25
$11.6M
Q1 25
$-1.6M
$-8.5M
Q4 24
$605.2K
$-2.7M
Q3 24
$-6.2M
$221.0K
Q2 24
$10.0M
Gross Margin
BIOX
BIOX
PI
PI
Q1 26
49.1%
Q4 25
51.8%
Q3 25
46.8%
50.3%
Q2 25
57.8%
Q1 25
39.4%
49.4%
Q4 24
42.0%
50.5%
Q3 24
40.2%
50.0%
Q2 24
56.1%
Operating Margin
BIOX
BIOX
PI
PI
Q1 26
30.5%
Q4 25
-2.9%
Q3 25
9.3%
0.7%
Q2 25
11.1%
Q1 25
1.5%
-12.9%
Q4 24
14.5%
-3.9%
Q3 24
2.5%
-0.8%
Q2 24
8.8%
Net Margin
BIOX
BIOX
PI
PI
Q1 26
11.2%
Q4 25
-1.2%
Q3 25
-9.6%
-13.3%
Q2 25
11.8%
Q1 25
-2.6%
-11.4%
Q4 24
0.6%
-2.9%
Q3 24
-6.6%
0.2%
Q2 24
9.7%
EPS (diluted)
BIOX
BIOX
PI
PI
Q1 26
$0.14
Q4 25
$-0.02
Q3 25
$-0.12
$-0.44
Q2 25
$0.39
Q1 25
$-0.02
$-0.30
Q4 24
$0.00
$-0.06
Q3 24
$-0.10
$0.01
Q2 24
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
PI
PI
Cash + ST InvestmentsLiquidity on hand
$15.5M
$131.8M
Total DebtLower is stronger
$241.5M
Stockholders' EquityBook value
$288.3M
Total Assets
$734.9M
$502.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
PI
PI
Q1 26
$131.8M
Q4 25
$175.3M
Q3 25
$15.5M
$190.1M
Q2 25
$193.2M
Q1 25
$38.5M
$147.9M
Q4 24
$29.2M
$164.7M
Q3 24
$32.3M
$170.3M
Q2 24
$220.2M
Total Debt
BIOX
BIOX
PI
PI
Q1 26
$241.5M
Q4 25
$280.9M
Q3 25
$280.4M
Q2 25
Q1 25
Q4 24
$283.5M
Q3 24
Q2 24
Stockholders' Equity
BIOX
BIOX
PI
PI
Q1 26
Q4 25
$209.2M
Q3 25
$288.3M
$195.0M
Q2 25
$187.7M
Q1 25
$345.0M
$160.6M
Q4 24
$346.3M
$149.9M
Q3 24
$346.0M
$136.1M
Q2 24
$117.0M
Total Assets
BIOX
BIOX
PI
PI
Q1 26
$502.5M
Q4 25
$545.2M
Q3 25
$734.9M
$516.5M
Q2 25
$508.8M
Q1 25
$798.2M
$479.8M
Q4 24
$835.2M
$489.1M
Q3 24
$827.3M
$476.4M
Q2 24
$446.1M
Debt / Equity
BIOX
BIOX
PI
PI
Q1 26
Q4 25
1.34×
Q3 25
1.44×
Q2 25
Q1 25
Q4 24
1.89×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
PI
PI
Operating Cash FlowLast quarter
$14.4M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
3.0%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$61.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
PI
PI
Q1 26
Q4 25
$15.1M
Q3 25
$14.4M
$20.9M
Q2 25
$33.9M
Q1 25
$23.3M
$-11.1M
Q4 24
$-5.4M
$12.6M
Q3 24
$5.2M
$10.1M
Q2 24
$45.5M
Free Cash Flow
BIOX
BIOX
PI
PI
Q1 26
$2.2M
Q4 25
$13.6M
Q3 25
$18.0M
Q2 25
$27.3M
Q1 25
$-13.0M
Q4 24
$8.5M
Q3 24
$4.7M
Q2 24
$44.1M
FCF Margin
BIOX
BIOX
PI
PI
Q1 26
3.0%
Q4 25
14.7%
Q3 25
18.7%
Q2 25
27.9%
Q1 25
-17.5%
Q4 24
9.3%
Q3 24
4.9%
Q2 24
43.0%
Capex Intensity
BIOX
BIOX
PI
PI
Q1 26
Q4 25
1.6%
Q3 25
3.1%
Q2 25
6.7%
Q1 25
2.5%
Q4 24
4.5%
Q3 24
5.7%
Q2 24
1.3%
Cash Conversion
BIOX
BIOX
PI
PI
Q1 26
Q4 25
Q3 25
Q2 25
2.93×
Q1 25
Q4 24
-8.85×
Q3 24
45.56×
Q2 24
4.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons